Terms: = Lymphoma AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2
157 results:
1. Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
Tam CS; Opat S; D'Sa S; Jurczak W; Lee HP; Cull G; Owen RG; Marlton P; Wahlin BE; García-Sanz R; McCarthy H; Mulligan S; Tedeschi A; Castillo JJ; Czyż J; Fernández De Larrea C; Belada D; Libby E; Matous J; Motta M; Siddiqi T; Tani M; Trněný M; Minnema MC; Buske C; Leblond V; Treon SP; Trotman J; Wu B; Yu Y; Shen Z; Chan WY; Schneider J; Allewelt H; Cohen A; Dimopoulos MA
Blood Adv; 2024 Apr; 8(7):1639-1650. PubMed ID: 38315878
[TBL] [Abstract] [Full Text] [Related]
2. Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors.
Hayashi T; Tateishi K; Matsuyama S; Iwashita H; Miyake Y; Oshima A; Honma H; Sasame J; Takabayashi K; Sugino K; Hirata E; Udaka N; Matsushita Y; Kato I; Hayashi H; Nakamura T; Ikegaya N; Takayama Y; Sonoda M; Oka C; Sato M; Isoda M; Kato M; Uchiyama K; Tanaka T; Muramatsu T; Miyake S; Suzuki R; Takadera M; Tatezuki J; Ayabe J; Suenaga J; Matsunaga S; Miyahara K; Manaka H; Murata H; Yokoyama T; Tanaka Y; Shuto T; Ichimura K; Kato S; Yamanaka S; Cahill DP; Fujii S; Shankar GM; Yamamoto T
Clin Cancer Res; 2024 Jan; 30(1):116-126. PubMed ID: 37851071
[TBL] [Abstract] [Full Text] [Related]
3. Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemia.
Catto LFB; Zanelatto LC; Donaires FS; de Carvalho VS; Santana BA; Pinto AL; Fantacini D; de Souza LEB; Fonseca NP; Telho BS; Ayrosa Madeira MI; Barbosa Pagnano KB; Firmato AB; Fagundes EM; Higashi M; Nunes EC; Traina F; Lobo de F Pontes L; Rego EM; Calado RT
Blood Adv; 2023 Nov; 7(22):7067-7078. PubMed ID: 37773887
[TBL] [Abstract] [Full Text] [Related]
4. Temporal trend in survival for chronic myelomonocytic leukemia in the US: a population-based study.
Lesegretain A; Brunner A; Benzohra A; Fathi AT
Leuk Lymphoma; 2023 Dec; 64(13):2156-2164. PubMed ID: 37715313
[TBL] [Abstract] [Full Text] [Related]
5. Fusion Oncogenes in Patients With Locally Advanced or Distant Metastatic Differentiated Thyroid Cancer.
Ju G; Sun Y; Wang H; Zhang X; Mu Z; Sun D; Huang L; Lin R; Xing T; Cheng W; Liang J; Lin YS
J Clin Endocrinol Metab; 2024 Jan; 109(2):505-515. PubMed ID: 37622214
[TBL] [Abstract] [Full Text] [Related]
6. The many faces of Atypical fibroxanthoma.
Agaimy A
Semin Diagn Pathol; 2023 Jul; 40(4):306-312. PubMed ID: 37438163
[TBL] [Abstract] [Full Text] [Related]
7. Mechanisms of theaflavins against gout and strategies for improving the bioavailability.
Chen J; Zheng Y; Gong S; Zheng Z; Hu J; Ma L; Li X; Yu H
Phytomedicine; 2023 Jun; 114():154782. PubMed ID: 36990009
[TBL] [Abstract] [Full Text] [Related]
8. PH negative acute lymphoblastic leukemia in adolescents and young adults treated according a MRD adapted BFM ALL IC 2009 protocol: Argentine real-world data on 171 patients.
Ferrari LC; Rivas MM; Navickas AB; Dick H; Mela Osorio MJ; Agamennoni L; Rey IH; Carnelutto NE; Cazap N; Castro MB; Aranguren PN; Fischman LA; Yupanki ML; Milone JH; Fernández II; Moirano MM; Belli CB;
Ann Hematol; 2023 May; 102(5):1087-1097. PubMed ID: 36892593
[TBL] [Abstract] [Full Text] [Related]
9. The Chemical Composition and Antimitotic, Antioxidant, Antibacterial and Cytotoxic Properties of the Defensive Gland Extract of the Beetle,
Sabira O; Vignesh AR; Ajaykumar AP; Varma SR; Jayaraj KN; Sebastin M; Nikhila K; Babu A; Rasheed VA; Binitha VS; Vasu ZK; Sujith MS
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364303
[TBL] [Abstract] [Full Text] [Related]
10. Real-world utility of early measurable residual disease assessments by multi-parametric flow cytometry in adult patients with B-lymphoblastic leukemia receiving Hyper-CVAD induction chemotherapy.
Nedumannil R; Ritchie D; Bajel A; Ng AP; Harrison SJ; Westerman D
Eur J Haematol; 2023 Feb; 110(2):168-176. PubMed ID: 36321745
[TBL] [Abstract] [Full Text] [Related]
11. Molecular markers related to patient outcome in patients with IDH-mutant astrocytomas grade 2 to 4: A systematic review.
Tesileanu CMS; Vallentgoed WR; French PJ; van den Bent MJ
Eur J Cancer; 2022 Nov; 175():214-223. PubMed ID: 36152406
[TBL] [Abstract] [Full Text] [Related]
12. Prospective longitudinal evaluation of treatment-related toxicity and health-related quality of life during the first year of treatment for pediatric acute lymphoblastic leukemia.
Schilstra CE; McCleary K; Fardell JE; Donoghoe MW; McCormack E; Kotecha RS; Lourenco RA; Ramachandran S; Cockcroft R; Conyers R; Cross S; Dalla-Pozza L; Downie P; Revesz T; Osborn M; Alvaro F; Wakefield CE; Marshall GM; Mateos MK; Trahair TN
BMC Cancer; 2022 Sep; 22(1):985. PubMed ID: 36109702
[TBL] [Abstract] [Full Text] [Related]
13. The genomic and transcriptional landscape of primary central nervous system lymphoma.
Radke J; Ishaque N; Koll R; Gu Z; Schumann E; Sieverling L; Uhrig S; Hübschmann D; Toprak UH; López C; Hostench XP; Borgoni S; Juraeva D; Pritsch F; Paramasivam N; Balasubramanian GP; Schlesner M; Sahay S; Weniger M; Pehl D; Radbruch H; Osterloh A; Korfel A; Misch M; Onken J; Faust K; Vajkoczy P; Moskopp D; Wang Y; Jödicke A; Trümper L; Anagnostopoulos I; Lenze D; Küppers R; Hummel M; Schmitt CA; Wiestler OD; Wolf S; Unterberg A; Eils R; Herold-Mende C; Brors B; ; Siebert R; Wiemann S; Heppner FL
Nat Commun; 2022 May; 13(1):2558. PubMed ID: 35538064
[TBL] [Abstract] [Full Text] [Related]
14. Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma.
Dlouhy I; Karube K; Enjuanes A; Salaverria I; Nadeu F; Ramis-Zaldivar JE; Valero JG; Rivas-Delgado A; Magnano L; Martin-García D; Pérez-Galán P; Clot G; Rovira J; Jares P; Balagué O; Giné E; Mozas P; Briones J; Sancho JM; Salar A; Mercadal S; Alcoceba M; Valera A; Campo E; López-Guillermo A
Br J Haematol; 2022 Feb; 196(3):589-598. PubMed ID: 34632572
[TBL] [Abstract] [Full Text] [Related]
15. Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma.
Fleming JL; Pugh SL; Fisher BJ; Lesser GJ; Macdonald DR; Bell EH; McElroy JP; Becker AP; Timmers CD; Aldape KD; Rogers CL; Doyle TJ; Werner-Wasik M; Bahary JP; Yu HM; D'Souza DP; Laack NN; Sneed PK; Kwok Y; Won M; Mehta MP; Chakravarti A
JCO Precis Oncol; 2021; 5():. PubMed ID: 34589661
[TBL] [Abstract] [Full Text] [Related]
16. Comparative Molecular Analysis of Primary Central Nervous System lymphomas and Matched Vitreoretinal lymphomas by Vitreous Liquid Biopsy.
Balikov DA; Hu K; Liu CJ; Betz BL; Chinnaiyan AM; Devisetty LV; Venneti S; Tomlins SA; Cani AK; Rao RC
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576156
[TBL] [Abstract] [Full Text] [Related]
17. Appropriate use criteria for ancillary diagnostic testing in dermatopathology: New recommendations for 11 tests and 220 clinical scenarios from the American Society of Dermatopathology Appropriate Use Criteria Committee.
; Fung MA; Vidal CI; Armbrecht EA; Andea AA; Cassarino DS; Comfere NI; Emanuel PO; Ferringer T; Hristov AC; Kim J; Lauer SR; Linos K; Missall TA; Motaparthi K; Novoa RA; Patel R; Shalin SC; Sundram U; ; Calame A; Bennett DD; Duncan LM; Elston DM; Hosler GA; Hurley YM; Lazar AJ; Lowe L; Messina J; Myles J; Plaza JA; Prieto VG; Reddy V; Schaffer A; Subtil A
J Cutan Pathol; 2022 Mar; 49(3):231-245. PubMed ID: 34536035
[TBL] [Abstract] [Full Text] [Related]
18. Expression of telomerase reverse transcriptase in peripheral T-cell lymphoma.
Arakawa F; Miyoshi H; Yoshida N; Nakashima K; Watatani Y; Furuta T; Yamada K; Moritsubo M; Takeuchi M; Yanagida E; Shimasaki Y; Kohno K; Kataoka K; Ohshima K
Cancer Med; 2021 Oct; 10(19):6786-6794. PubMed ID: 34477310
[TBL] [Abstract] [Full Text] [Related]
19. The long-term outcome and risk factors for precursor B cell acute lymphoblastic leukemia without specific fusion genes in Chinese children: experiences from multiple centers.
Zou P; Zhou M; Wen J; Liao X; Shen Y; Liu H; Song L; Xiao J
Bosn J Basic Med Sci; 2022 Apr; 22(2):238-246. PubMed ID: 34392828
[TBL] [Abstract] [Full Text] [Related]
20. Human tert promoter polymorphism rs2853669 is associated with cancers: an updated meta-analysis.
Aziz MA; Jafrin S; Islam MS
Hum Cell; 2021 Jul; 34(4):1066-1081. PubMed ID: 33743166
[TBL] [Abstract] [Full Text] [Related]
[Next]
